Drug of choice in interstitial lung disease is
Glucocoicoids are the mainstay of therapy for suppression of the alveolitis present in ILD.Glucocoicoid therapy is recommended for symptomatic ILD patients with eosinophilic pneumonias,sarcoidosis,hypersensitivity pneumonitis,acute inorganic dust exposures,acute radiation pneumonitis,drug-induced ILD.In organic dust disease,glucocoicoids are recommended for both the acute and chronic stages.A common staing dose of steroid is prednisone,0.5-1 mg/kg in a once-daily oral dose.This dose is continued for 4-12 weeks,at which time the patient is reevaluated.If the patient is stable or improved,the dose is tapered to 0.25-0.5 mg/kg and is maintained at this level for an additional 4-12 weeks,depending on the course.If the patient's condition continues to decline on glucocoicoids,a second agent like cyclophosphamide,azathioprine,methotrexate,colchicine,pencillamine ,etc can be added, and the prednisolone dose is lowered to or maintained at 0.25 mg/kg per dose. Ref:Harrison's medicine-18th edition,page no:2164-2165.
Antibiotics
Steroid
Bronchodilators
none
Respiratory system